Influence of modifiable cardiovascular risk factors on antihypertensive therapy efficiency escape
- Authors: Mikhailova OO1,2, Litvin AY.1,2, Rogoza AN1,2
-
Affiliations:
- НИИ кардиологии им. А.Л. Мясникова
- ФГБУ РКНПК Минздрава Российской Федерации
- Issue: Vol 89, No 9 (2017)
- Pages: 10-14
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32264
- DOI: https://doi.org/10.17116/terarkh201789910-14
- ID: 32264
Cite item
Full Text
Abstract
Aim. To evaluate the influence of cardiovascular risk factors on antihypertensive therapy (AHT) efficiency escape (EE). Subjects and methods. Data on 59 patients with grades 1—3 hypertension (Stages I—II) were analyzed. During chosen AHT, 24-hour blood pressure monitoring was done at baseline, 1 and 3 months after beginning the observation to identify/rule out the AHT EE phenomenon. Results. The AHT EE group (Group 1) as compared with the group that needed no therapy correction within 3 months (Group 2) was observed to have the following: elevated fasting blood glucose levels (FBGL) (5.8±0.8 vs 5.3±0.7 mmol/l; p=0.008) and higher impaired glucose tolerance (IGT) rates (8 (27.6%) vs 4 (13.3%) cases (p=0.03)); a more number of smoking patients (8 (27.6%) vs 3 (10%) cases; p=0.02); a larger number of patients with a compromised family history of cardiovascular diseases (17 (58.6%) vs 11 (36%); p=0.02). Furthermore, in Group 1 baseline average systolic blood pressure during 24 hours (SBP-24) proved to be higher than that in Group 2 (127.4±4.2 vs 122.4±6.8 mm Hg; p=0.002). Odds ratio (OR) for developing the EE phenomenon increased by 60% with a rise of 0.5 mmol in FBGL (OR, 1.60; 95% confidence interval (CI), 1.06 to 2.4; p=0.02) and by 18% with an increase of 1 mm Hg in baseline SBP-24 (OR, 1.18; 95% CI, 1.05 to 1.33; p=0.004). Multivariate analysis indicated that the independent predictors of AHT EE were a compromised family history (OR, 3.7; 95% CI, 1.1 to 12.1; p=0.03) and IGT (OR, 4.1; 95% CI, 1.02 to 16.4; p=0.04). Conclusion. AHT EE was influenced by FBGL, IGT, smoking, a compromised family history, and baseline SBP-24 level.
Full Text
##article.viewOnOriginalSite##About the authors
O O Mikhailova
НИИ кардиологии им. А.Л. Мясникова; ФГБУ РКНПК Минздрава Российской ФедерацииМосква, Россия
A Yu Litvin
НИИ кардиологии им. А.Л. Мясникова; ФГБУ РКНПК Минздрава Российской ФедерацииМосква, Россия
A N Rogoza
НИИ кардиологии им. А.Л. Мясникова; ФГБУ РКНПК Минздрава Российской ФедерацииМосква, Россия
References
- Bowman T, Gaziano J, Buring J, Sesso H. A Prospective Study of Cigarette Smoking and Risk of Incident Hypertension in Women. Journal of the American College of Cardiology. 2007;50(21):2085-2092. https://doi.org/10.1016/j.jacc.2007.08.017
- Halperin R, Michael Gaziano J, Sesso H. Smoking and the Risk of Incident Hypertension in Middle-aged and Older Men. American Journal of Hypertension. 2008;21(2):148-152. https://doi.org/10.1038/ajh.2007.36
- Castelli W, Anderson K. A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham study. The American Journal of Medicine. 1986;80(2):23-32. https://doi.org/10.1016/0002-9343(86)90157-9
- Anderson K. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA: The Journal of the American Medical Association. 1987;257(16):2176-2180. https://doi.org/10.1001/jama.257.16.2176
- Haffner S. Metabolic precursors of hypertension. The San Antonio Heart Study. Archives of Internal Medicine. 1996; 156(17):1994-2001. https://doi.org/10.1001/archinte.156.17.1994
- Zhou L, Liu H, Wen X, Peng Y, Tian Y, Zhao L. Effects of metformin on blood pressure in nondiabetic patients. Journal of Hypertension. 2017;35(1):18-26. https://doi.org/10.1097/hjh.0000000000001119
- Kjeldsen, S., Narkiewicz, K., Oparil, S. and Hedner, T. 2013 European Society of Hypertension/European Society of Cardiology Hypertension Guidelines. Blood Pressure. 2013; 22(4):191-192.
- Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. American Heart Journal. 2004;148(2):285-292. https://doi.org/10.1016/j.ahj.2004.02.003
- Levin G, Kestenbaum B, Ida Chen Y et al. Glucose, Insulin, and Incident Hypertension in the Multi-Ethnic Study of Atherosclerosis. American Journal of Epidemiology. 2010;172(10):1144-1154. https://doi.org/10.1093/aje/kwq266
- Silva R, Silva D, Bastos J, Peres K, Peres M, González-Chica D. Anthropometric measures change and incidence of high blood pressure levels among adults. Journal of Hypertension. 2017; 35(1):39-46. https://doi.org/10.1097/hjh.0000000000001128
- Seven E, Husemoen L, Wachtell K, Ibsen H, Linneberg A, Jeppesen J. Five-year weight changes associate with blood pressure alterations independent of changes in serum insulin. Journal of Hypertension. 2014;32(11):2231-2237. https://doi.org/10.1097/hjh.0000000000000317
- Berglund GWilhelmsen L. Factors Related to Blood Pressure in a General Population Sample of Swedish Men. Acta Medica Scandinavica. 2009;198(1-6):291-298. https://doi.org/10.1111/j.0954-6820.1975.tb19543.x
- Seltzer C. Effect of smoking on blood pressure. American Heart Journal. 1974;87(5):558-564. https://doi.org/10.1016/0002-8703(74)90492-x
- Lee D, Ha M, Kim J, Jacobs D. Effects of Smoking Cessation on Changes in Blood Pressure and Incidence of Hypertension : A 4-Year Follow-Up Study. Hypertension. 2001;37(2):194-198. https://doi.org/10.1161/01.hyp.37.2.194
- Tamura U, Tanaka T, Okamura T et al. Changes in Weight, Cardiovascular Risk Factors and Estimated Risk of Coronary Heart Disease Following Smoking Cessation in Japanese Male Workers: HIPOP-OHP Study. Journal of Atherosclerosis and Thrombosis. 2010;17(1):12-20. https://doi.org/10.5551/jat.1800
- Жернакова Ю.В., Шарипова Г.Х., Чазова И.Е. Артериальная гипертония у больных с метаболическими нарушениями: особенности и тактика лечения. Системные гипертензии. 2015;1:52-57.
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine. 2016;374(23):2290-2295. https://doi.org/10.1056/nejmc1602668
- Eva M Lonn, Jackie Bosch, Patricio López-Jaramillo, et al. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. New England Journal of Medicine. 2016;374:2009-2020. https://doi.org/10.1056/NEJMoa1600175
![](/img/style/loading.gif)